illumina is loosing its all time illumination.illumina is loosing its all time illumination. Looks like a change in fundamental business model is required to turn into market favorite
−0.01 BRL
−5.80 B BRL
22.50 B BRL
About Illumina, Inc.
Sector
Industry
CEO
Jacob Thaysen
Website
Headquarters
San Diego
Founded
1998
ISIN
BRI1LMBDR007
FIGI
BBG00RD64QH2
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where I1LM34 is featured.
